Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT)

225 filings reported holding ADPT - Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share as of Q1 2024.
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) has 185 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 142M shares of 152M outstanding shares and own 93.73% of the company stock.
Largest 10 shareholders include VIKING GLOBAL INVESTORS LP (30M shares), VANGUARD GROUP INC (12.9M shares), Matrix Capital Management Company, LP (11.6M shares), BlackRock Inc. (11.2M shares), ARK Investment Management LLC (10.6M shares), Rubric Capital Management LP (10.5M shares), Sumitomo Mitsui Trust Holdings, Inc. (6.18M shares), Nikko Asset Management Americas, Inc. (6.18M shares), PICTET ASSET MANAGEMENT Holding SA (3.5M shares), and Aristotle Atlantic Partners, LLC (2.99M shares).
This table shows the top 185 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.